
About
This secure messaging application is designed for healthcare professionals to communicate sensitive patient information. Access requires an account provided by the organization or the service provider.
What's New in Third Eye Health
4.0.21
February 3, 2026
Bug Fixes
User reviews
FAQ
What is Third Eye Health - SecureChat used for?
Third Eye Health - SecureChat is an enterprise application specifically designed for nurses and doctors to securely communicate patient information. It ensures that sensitive data is exchanged safely within a healthcare organization.
How do I access Third Eye Health - SecureChat?
To access Third Eye Health - SecureChat, you must have an account provided by Third Eye Health or your specific organization. This is an enterprise solution, not a public-facing app.
Is Third Eye Health - SecureChat free to use?
Yes, the application is listed as free. However, access is contingent on having an organizational account, which may involve costs for the institution.
What devices support Third Eye Health - SecureChat?
Third Eye Health - SecureChat is available on iPhone, iPad, and iPod devices. This ensures broad compatibility for healthcare professionals using Apple mobile devices.
What is the age rating for Third Eye Health - SecureChat?
The app has an age rating of 4+, indicating it is suitable for users of all ages. This rating is common for utility applications.
When was Third Eye Health - SecureChat last updated?
The latest version, 4.0.21, was updated on February 3, 2026. This indicates a recent focus on development and maintenance for the application.
Does Third Eye Health - SecureChat have ads?
No, Third Eye Health - SecureChat does not contain advertisements. As an enterprise communication tool, it prioritizes a clean and uninterrupted user experience for healthcare professionals.
What is the user sentiment for Third Eye Health - SecureChat?
Based on the available data, Third Eye Health - SecureChat has a high rating of 4.7 stars from 7 ratings. This suggests a generally positive user experience among its limited reviewer base.




